This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Elsevier Announces The Launch Of Open Access Journal: 'Neurobiology Of Stress'

Stocks in this article: REN ENL RUK

OXFORD, England, August 14, 2014 /PRNewswire/ --

Elsevier, world-leading provider of scientific, technical and medical information products and services, is pleased to announce the launch of a new open access journal: Neurobiology of Stress.

The journal will serve as a forum for original research and review articles focusing on the impact of stress on the brain, covering cellular, behavioral functions and stress-related neuropsychiatric disorders such as depression, trauma and anxiety. The translation of basic research findings into real-world applications will be a key aim of the journal.

Stress affects everyone at some point in their lives and is increasingly becoming an issue in today's society. More people are coming under mounting pressures at work, at home and in their social lives.

As a result increasing funding is being made available to conduct research in these areas and therefore the volume of publications dealing with stress is likely to continue to grow in the years to come. We intend that Neurobiology of Stress will help to progress basic research and ultimately develop targeted treatment opportunities for stress-related mental health disorders.

Co-Editor-in-Chief Rita Valentino, Research Professor of Anesthesiology and Critical Care and Director of the Division of Stress Neurobiology at the Children's Hospital of Philadelphia commented: "Recognizing the broad impact of stress on neurobehavioral processes and diseases, research from diverse disciplines has converged on stress neurobiology in recent years. This journal will serve as a forum for timely research and conceptual perspectives in basic and clinical stress neuroscience."

"We are very excited about the launch of the journal. It will provide a home for high quality original research and review papers in this growing field," said Co-Editor-in-Chief, Yvette Sheline, Professor of Psychiatry at the Perelman School of Medicine at the University of Pennsylvania.

Toby Charkin, Executive Publisher for behavioral and cognitive neuroscience journals at Elsevier, added: "I believe Neurobiology of Stress will fill an important niche because of the tremendous growth in stress research in recent years. Clinical awareness of the influence of different types of stress on disease development and recovery is increasing and research being conducted today will have the potential to underpin new treatment paradigms. Also publishing it open access will ensure that the information is freely available for the widest possible audience, which may bring added benefits due to the multidisciplinary nature of research in the field."

For more information or to submit an article, go to: http://www.journals.elsevier.com/neurobiology-of-stress

First articles will be published and available through ScienceDirect by November 2014.

About Open Access Publishing at Elsevier 

Elsevier has been providing open access publishing options since 2005. Today, researchers can choose to publish open access in over 1,600 established peer-reviewed journals as well as over 100 full open access journals and these numbers will continue to grow rapidly. All of Elsevier's open access publications have been peer reviewed, ensuring that the broader community not only reads the latest research but that it is factual, original and of the highest quality and ethical standards. For more information about Elsevier's open access program, visit http://www.elsevier.com/openaccess.

About Elsevier 

Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions - among them ScienceDirect, Scopus, Elsevier Research Intelligence and ClinicalKey - and publishes nearly 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.

The company is part of Reed Elsevier Group PLC, a world-leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media contact Joanna Cipolla Elsevier +44-18-65-84-34-77 j.cipolla@elsevier.com

 

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,890.18 +85.38 0.48%
S&P 500 2,073.65 +3.00 0.14%
NASDAQ 4,777.5770 +12.1970 0.26%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs